Analysis

Microsoft's equity has experienced its most challenging start to a year since the 2008 financial crisis, declining approximately 19% since...

While a net loss exceeding $12 billion in the final quarter of 2025 would typically trigger a sell-off, the market’s...

Uranium Energy Corp. has demonstrated the tangible benefits of its unhedged sales strategy in its latest quarterly report. The company...

Apple is on the cusp of one of its most significant product transitions in nearly two decades. The company's roadmap...

The stock of biotechnology firm Ocugen has experienced a significant rally, propelled by a combination of promising clinical developments for...

Pharmaceutical leader Eli Lilly continues to solidify its position in the weight-loss medication sector. The company is benefiting from a...

For the first time in its history, automation software specialist UiPath has closed its fiscal year with a GAAP net...

Recent regulatory filings with the U.S. Securities and Exchange Commission (SEC) have provided a fresh look at the equity stakes...

Campbell Soup Company is facing a multi-pronged challenge, with disappointing quarterly earnings and a significant reduction in its annual forecast...

Investors in Spero Therapeutics are closely monitoring the coming weeks, which could prove pivotal for the company’s fight against multidrug-resistant...